Smartleaf Asset Management’s Pacira BioSciences PCRX Stock Holding History

Smartleaf Asset Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.19K	Sell	352 -410	-54%	-$9.11K	﹤0.01%	2422
2025 Q4	$19.9K	Buy	762 +183	+32%	+$4.35K	﹤0.01%	2038
2025 Q3	$14.7K	Buy	579 +410	+243%	+$10.1K	﹤0.01%	1948
2025 Q2	$3.97K	Sell	169 -249	-60%	-$6.28K	﹤0.01%	2122
2025 Q1	$10.4K	Sell	418 -7	-2%	-$168	﹤0.01%	1914
2024 Q4	$8.05K	Buy	425 +394	+1,271%	+$6.92K	﹤0.01%	2077
2024 Q3	$450	Sell	31 -236	-88%	-$4.04K	﹤0.01%	2791
2024 Q2	$7.45K	Buy	+267	New	+$7.6K	﹤0.01%	1577

Other funds holding PCRX

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return